Mike Sayama left the role of Director at SBC Medical Group Holdings Inc. As of November 6, 2026, SBC Medical Group Holdings Inc has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on May 20, 2026, naming 1 departure (Form 8-K, May 20, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like SBC Medical Group Holdings Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
SBC Medical Group Holdings Inc reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-05-20. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as SBC Medical Group Holdings Inc files it.
Also on the record for SBC Medical Group Holdings Inc
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| April 21, 2026 | Stake report, Schedule 13D/A, by Yoshiyuki Aikawa | 82.2% of the class | 5%+ stakes | Source |
| March 13, 2026 | Stake report, Schedule 13G, by Aikawa Equity Management Co., Ltd. | 5.2% of the class | 5%+ stakes | Source |
| March 10, 2026 | Stake report, Schedule 13D/A, by Yoshiyuki Aikawa | 85.2% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs SBC Medical Group Holdings Inc now and the warning signs.
Free to see. No signup.
Keep reading
More on SBC Medical Group Holdings Inc and the records around it.
SBC Medical Group Holdings Inc elsewhere on the record
- 5%+ stake filings Apr 2026
- Who owns it
Watch SBC Medical Group Holdings Inc
Get an email when SBC Medical Group Holdings Inc files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on SBC Medical Group Holdings Inc?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on SBC Medical Group Holdings Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on SBC Medical Group Holdings Inc covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
4 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-05-20 | Out | Director | 8-K, 2026-05-20 |
Who leads SBC Medical Group Holdings Inc, as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Director: Mike Sayama, departure reported (filed 2026-05-20). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on SBC Medical Group Holdings Inc: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Director at SBC Medical Group Holdings Inc, with the record behind each one.
Find candidates like Director at SBC Medical Group Holdings IncEvery change, in the filing's words
Departing: Mike Sayama, Director
On May 14, 2026, Mike Sayama, an independent director of SBC Medical Group Holdings Incorporated (the "Company"), notified the Company that he would not seek re-election at the Company's forthcoming 2026 Annual Meeting of Stockholders (the "2026 AGM").
- The Company's board of directors has reduced the size of the board of directors to four members, effective as of immediately prior to the opening of the polls at the 2026 AGM.
- Mr. Sayama's decision to not pursue re-election was not due to any disagreement with the Company, its management, or the board of directors on any matter relating to the Company's operations, policies or practices.
- The Company plans to file with the U.S. Securities and Exchange Commission (the "SEC") a definitive proxy statement (the "Proxy Statement") in connection with the 2026 AGM.
- Investors and security holders are urged to read the Proxy Statement carefully when it is available and will be able to obtain free copies of the Proxy Statement and other documents filed with the SEC by the Company through the website maintained by the SEC at www.sec.gov.
- Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading "Risk Factors" and elsewhere in the Company's filings with the SEC, which are accessible on the SEC's website at www.sec.gov.
Tools for this story
Each opens in a new tab, filled in for SBC Medical Group Holdings Inc. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.